Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.
作者信息
Gerner R E, Moore G E, Didolkar M S
出版信息
Cancer. 1973 Oct;32(4):756-60. doi: 10.1002/1097-0142(197310)32:4<756::aid-cncr2820320404>3.0.co;2-6.
Abstract
摘要
相似文献
1
Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.
Cancer. 1973 Oct;32(4):756-60. doi: 10.1002/1097-0142(197310)32:4<756::aid-cncr2820320404>3.0.co;2-6.
2
Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.
Cancer Chemother Rep. 1973 Feb;57(1):83-4.
3
Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
Cancer Chemother Rep. 1972 Oct;56(5):671-7.
4
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide.
Cancer. 1972 Dec;30(6):1632-8. doi: 10.1002/1097-0142(197212)30:6<1632::aid-cncr2820300632>3.0.co;2-s.
5
Effective treatment of Kaposi's sarcoma with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
Cancer Chemother Rep. 1973 Feb;57(1):65-71.
6
Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):753-4.
7
Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.
Cancer. 1973 Oct;32(4):749-55. doi: 10.1002/1097-0142(197310)32:4<749::aid-cncr2820320403>3.0.co;2-1.
8
Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.
Clin Pharmacol Ther. 1971 Nov-Dec;12(6):955-62. doi: 10.1002/cpt1971126955.
9
Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
Cancer. 1974 Mar;33(3):615-8. doi: 10.1002/1097-0142(197403)33:3<615::aid-cncr2820330304>3.0.co;2-f.
10
5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
Eur J Cancer (1965). 1972 Feb;8(1):85-92. doi: 10.1016/0014-2964(72)90087-4.
引用本文的文献
1
Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects.
Nat Commun. 2020 Dec 1;11(1):6136. doi: 10.1038/s41467-020-19950-z.
2
Peripheral DTIC neurotoxicity: a case report.
Cancer Chemother Pharmacol. 1987;19(1):87-8. doi: 10.1007/BF00296264.
Zotero 插件